|
||
New Keele Spin-Out Company Attracts InvestmentNanoTherics Ltd has secured investment from the Mercia Technology Seed Fund. Co-founders Prof Jon Dobson and Dr Neil Farrow are developing non-viral gene transfection systems for key research applications, drug screening and gene therapy/clinical applications. The technology was developed at Keele from research into cystic fibrosis and has the potential to be become the "gold standard" for this procedure, which facilitates the transfer of DNA into cells, and is hoped to eventually lead methods of treating human conditions. You can find the nanoTherics website at http://www.nanotherics.com/
|
This week:New Keele Spin-Out Company Attracts Investment Keynote Speaker in National Debate Keele University Researcher Chairs Royal Society Discussion Meeting Routes Into Languages Residential Course Biodegradable and Reusable Carrier Bags at Select And Save Social Innovation Expert Speaks At Keele Paper by Keele Professor among Most Cited Journal Articles in Software Engineering |
|
| top of page | Web Managers
for Chris
Stone Last modified: 12-Sep-2006 |